Page 39 - The Indian EYE 020521
P. 39
Business EYE February 05, 2021 | The Indian Eye 39
BUSINESS BRIEFS
tata Boeing aerospace to make Zydus cadila’s
737 Vertical fin structures net profit up 41% in Q3 to
in hyderabad rs 527 crore
oeing on Friday an- tical fin structures for 737-fami- harmaceutical major Zy- tions business in India grew by
nounced the addition of ly of airplanes,” the statement dus Cadila said on Friday 21 per cent, consumer wellness
Ba new production line at said. KT Rama Rao, Telanga- Pits profit after tax was up business by 16 per cent and an-
its joint venture, Tata Boeing na Municipal Administration by 41 per cent to Rs 527 crore imal health business by 17 per
Aerospace Limited (TBAL) and Industries Minister said, in Q3 FY21 as compared to the cent. US formulations business
in Hyderabad, to manufacture “This is a noteworthy step in corresponding quarter of pre- registered revenues of Rs 1,603
complex vertical fin structures the growth of India’s aerospace vious year. Consolidated reve- crore during the quarter. The
for 737-family of airplanes. and defence manufacturing.” nues moved up by 4 per cent to company filed 10 additional ab-
“Spread over 14,000 square “Telangana is an established Rs 3,796 crore consolidated net breviated new drug applications
meters, the state-of-the-art fa- hotbed for India’s defence and sales by 6 per cent to Rs 3,754 (ANDAs) with the US Food
cility has been producing ae- aerospace industry supported crore. Earnings before interest, and Drug Administration, tak-
ro-structures for Boeing’s AH- by a robust ecosystem, including depreciation and tax (EBIDTA) ing the cumulative number of
64 Apache helicopter, including a large pool of skilled and in- were up by 16 per cent to Rs 807 filings to 410, and received nine
fuselages, secondary structures, dustry-ready work-force. I con- crore. The company’s business new product approvals (includ-
and vertical spar boxes for cus- gratulate Boeing and Tata for in India, which comprises hu- ing four tentative approvals).
tomers worldwide,” Boeing said this milestone,” he added. Salil man health formulations busi- During the quarter, the com-
a statement. “Boeing today an- Gupte, president of Boeing In- ness, consumer wellness busi- pany launched the oral anti-di-
nounced addition of a new pro- dia said that the latest develop- ness and animal health business abetic agent Dapaglyn (Da-
duction line at its joint venture, ment is an example of Boeing’s posted 20 per cent growth in pagliflozin) in India for patients
Tata Boeing Aerospace Limited commitment towards co-devel- the quarter ended December suffering from chronic obstruc-
(TBAL) in Hyderabad, Telanga- opment of integrated systems in 2020 with revenues of Rs 1,643 tive pulmonary disorder. Zydus
na, to manufacture complex ver- aerospace and defence in India. crore. Human health formula- Cadila launched Forglyn,
www.TheIndianEYE .com
